AU2002232470B2 - New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents - Google Patents

New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents Download PDF

Info

Publication number
AU2002232470B2
AU2002232470B2 AU2002232470A AU2002232470A AU2002232470B2 AU 2002232470 B2 AU2002232470 B2 AU 2002232470B2 AU 2002232470 A AU2002232470 A AU 2002232470A AU 2002232470 A AU2002232470 A AU 2002232470A AU 2002232470 B2 AU2002232470 B2 AU 2002232470B2
Authority
AU
Australia
Prior art keywords
disorder
syndrome
mg
stress
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002232470A
Other versions
AU2002232470A1 (en
Inventor
Christopher C. Gallen
Torgny Svensson
Erik Ho Fong Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia AB
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia AB
Pharmacia and Upjohn Co Inc
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US25928601P priority Critical
Priority to US60/259,286 priority
Application filed by Pharmacia AB, Pharmacia and Upjohn Co Inc, Pharmacia and Upjohn Co LLC filed Critical Pharmacia AB
Priority to PCT/US2001/045871 priority patent/WO2002053140A2/en
Publication of AU2002232470A1 publication Critical patent/AU2002232470A1/en
Application granted granted Critical
Publication of AU2002232470B2 publication Critical patent/AU2002232470B2/en
Application status is Ceased legal-status Critical
Anticipated expiration legal-status Critical

Links